molsidomine has been researched along with oxidopamine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alm, P; Andersson, KE; Johansson, K; Larsson, B; Persson, K | 1 |
| Maruyama, W; Naoi, M; Youdim, MB | 1 |
| Maruyama, W; Naoi, M | 1 |
| Cao, TT; Hess, JF; Kandpal, G; Ma, L; Seabrook, GR; Warren, L | 1 |
| Amit, T; Bar-Am, O; Blumenfeld, Z; Kupershmidt, L; Youdim, MB | 1 |
| D'angelo, V; Galati, S; Martorana, A; Procopio, T; Sancesario, G; Scarnati, E; Stanzione, P; Stefani, A | 1 |
| Benigno, A; Crescimanno, G; Di Giovanni, G; Di Matteo, V; Esposito, E; Pierucci, M | 1 |
| Amit, T; Bar-Am, O; Gross, Z; Kupershmidt, L; Mahammed, A; Mandel, S; Okun, Z; Saltsman, I; Youdim, MB | 1 |
| Czarnecka, A; Kamińska, K; Konieczny, J; Lenda, T; Lorenc-Koci, E | 1 |
| Czarnecka, A; Domin, H; Konieczny, J; Lenda, T; Lorenc-Koci, E; Smiałowska, M | 1 |
| Czarnecka, A; Dudek, M; Kamińska, K; Knutelska, J; Lorenc-Koci, E; Zygmunt, M | 1 |
11 other study(ies) available for molsidomine and oxidopamine
| Article | Year |
|---|---|
Morphological and functional evidence against a sensory and sympathetic origin of nitric oxide synthase-containing nerves in the rat lower urinary tract.
Topics: Acetylcholinesterase; Animals; Antibody Specificity; Arginine Vasopressin; Calcitonin Gene-Related Peptide; Capsaicin; Enzyme Inhibitors; Female; Gold Colloid; Microscopy, Electron; Molsidomine; Neurons, Afferent; Neuropeptide Y; Nitric Oxide Synthase; Nitroarginine; Oxidopamine; Rats; Rats, Sprague-Dawley; Substance P; Sympathectomy, Chemical; Sympathetic Fibers, Postganglionic; Sympatholytics; Tyrosine 3-Monooxygenase; Urethra; Urothelium; Vasoconstrictor Agents; Vasodilator Agents | 1997 |
Antiapoptotic properties of rasagiline, N-propargylamine-1(R)-aminoindan, and its optical (S)-isomer, TV1022.
Topics: Adrenergic Agents; Apoptosis; Cell Line; Humans; Indans; Molsidomine; Neuroprotective Agents; Nitric Oxide Donors; Oxidopamine; Pargyline; Propylamines; Stereoisomerism | 2001 |
Future of neuroprotection in Parkinson's disease.
Topics: Apoptosis; Humans; Molsidomine; Neuroprotective Agents; Neurotoxins; Nitric Oxide Donors; Oxidopamine; Parkinson Disease; Propylamines; Salsoline Alkaloids; Selegiline; Tetrahydroisoquinolines; Tumor Cells, Cultured | 2001 |
Increased nuclear factor-erythroid 2 p45-related factor 2 activity protects SH-SY5Y cells against oxidative damage.
Topics: 1-Methyl-4-phenylpyridinium; Blotting, Western; Cell Survival; DNA-Binding Proteins; Genes, Reporter; Humans; Hydroquinones; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Luciferases; Molsidomine; NF-E2-Related Factor 2; Oxidative Stress; Oxidopamine; Plasmids; Proteins; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Signal Transduction; Trans-Activators | 2005 |
The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases.
Topics: Activins; Animals; Apoptosis; Apoptosis Regulatory Proteins; Brain; Cell Line, Tumor; Cell Survival; Culture Media, Serum-Free; Histones; Humans; Molsidomine; Nerve Degeneration; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidative Stress; Oxidopamine; PC12 Cells; Poly(ADP-ribose) Polymerases; Rats; Transfection; Tyrosine 3-Monooxygenase | 2007 |
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway.
Topics: Action Potentials; Analysis of Variance; Animals; Corpus Striatum; Cyclic GMP; Denervation; Dopamine; Dose-Response Relationship, Radiation; Electric Stimulation; Enzyme Inhibitors; Male; Molsidomine; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidopamine; Rats; Rats, Wistar; Signal Transduction; Sympatholytics | 2008 |
Involvement of nitric oxide in nigrostriatal dopaminergic system degeneration: a neurochemical study .
Topics: Animals; Corpus Striatum; Indazoles; Male; Molsidomine; Nitric Oxide; Nitric Oxide Donors; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2009 |
Metallocorroles as cytoprotective agents against oxidative and nitrative stress in cellular models of neurodegeneration.
Topics: Animals; Caspase 3; Cell Count; Cell Death; Cell Line, Tumor; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Enzyme Inhibitors; Humans; Hydrogen Peroxide; In Situ Nick-End Labeling; Metalloporphyrins; Mice; Molsidomine; Motor Neurons; Neuroblastoma; Neuroprotective Agents; Nitrates; Oxidative Stress; Oxidopamine; Porphyrins; Sympatholytics | 2010 |
Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA.
Topics: Animals; Behavior, Animal; Corpus Striatum; Levodopa; Male; Molsidomine; Nitric Oxide Donors; Oxidopamine; Rats; Rats, Wistar; Substantia Nigra | 2013 |
Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Blotting, Western; Immunohistochemistry; Levodopa; Male; Molsidomine; NADPH Dehydrogenase; Neurons; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra; Subthalamic Nucleus | 2013 |
Contribution of the nitric oxide donor molsidomine and the antiparkinsonian drug l-DOPA to the modulation of the blood pressure in unilaterally 6-OHDA-lesioned rats.
Topics: Animals; Antiparkinson Agents; Blood Pressure; Levodopa; Male; Molsidomine; Nitric Oxide Donors; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar | 2017 |